Product Details
| Product Name:
AZ3976 |
CAS No.:
1418747-15-5 |
| Purity:
98.01% |
Supply Ability:
10g |
| Release date:
2024/11/19 |
Product Introduction
Bioactivity
| Name | AZ3976 |
| Description | AZ3976 is an inhibitor of PAI-1 with an IC50 of 16 μM in a plasma clot lysis assay. AZ3976 displays profibrinolytic activities. |
| In vitro | AZ3976 is active with an IC50 value of 26 μM in an enzymatic chromogenic assay. AZ3976 enhances the latency transition of active PAI-1 and inhibits PAI-1[1]. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility Information | DMSO : 45 mg/mL (141.8 mM)
|
| Keywords | AZ3976 |
| Inhibitors Related | Toddalolactone | TM5275 sodium | GW-6604 | Upamostat | TM5441 | Angstrom6 | Aleplasinin | Loureirin B | UK-371804 | Tiplaxtinin | TM5007 |
| Related Compound Libraries | Bioactive Compound Library | Inhibitor Library | Bioactive Compounds Library Max |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:325746-94-9
$290.00 / 5mg
-
CAS:183499-57-2
$198.00 / 5mg
-
CAS:3458-14-8
$89.00 / 5mg
Recommended supplier
| Product name |
Price |
|
Suppliers |
Update time |
|
|
$/ |
|
Anhui Ruihan Technology Co., Ltd
|
2023-08-21 |
United States